Afaxys Adopts Public Benefit Corporation Status in Line with Its Mandate of Serving Public Health
CHARLESTON, S.C. – Afaxys, LLC, known for its commitment towards serving public health professionals and their patients, announced today that it has taken a significant step forward by structuring itself as a Public Benefit Corporation (PBC). This move underpins Afaxys’ commitment to over 31 million American citizens who depend on the public health system safety net for essential care, including reproductive and sexual health care.
Afaxys’ Dedication to Public Health
Unlike traditional corporations where profit is a primary focus, the transition to a PBC indicates an unabating commitment towards balancing social purpose with their business operations. This shift enables a reinforcement of long-term value creation and reinforces alignment with their mission.
Ronda Dean, President, CEO & Co-Founder of Afaxys, said, “Afaxys was established in 2008 with an aim to assure long-term, well-managed supply of essential contraceptives and other medical products for public health family planning providers. Over the years, our mission has evolved as our business has grown. However, our core purpose remains unwavering — to serve the society’s best interests. I’m incredibly proud of this transition to a PBC as it represents our continuous commitment to the significant purpose we set for ourselves over 15 years ago.”
Updated Mission Statement
Following this change, Afaxys has also updated its mission statement. The public benefit purpose of Afaxys, Inc. is to advance health equity and contribute to a healthier, more empowered society by ensuring every individual has access to the healthcare resources they need to lead a fulfilling life. Afaxys is dedicated to providing public health professionals with access to high-quality products for their patients.
About Afaxys
Now a Public Benefit Corporation, Afaxys has established unique partnerships within public health and private sectors to assure healthcare providers can access products and services they require at stable prices and with reliable access. The Afaxys organization includes a family of companies that function under two wholly-owned subsidiaries: Afaxys Pharma, LLC, and Afaxys Group Services, LLC (AGS).
Afaxys Pharma delivers a broad portfolio of branded and generic contraceptives to the public healthcare market. On the other hand, AGS is a strategic sourcing operation that procures favourable pricing across a broad base of products and services through its Group Purchasing Organization and emapp.
This robust change to a PBC is a firm indication of Afaxys’ steadfast commitment to health equity and their continuous dedication to serving public health needs. For additional information, visit www.afaxys.com.
